You will now be redirected to the GD3 website
Invivotek is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.Learn more about GD3
We work with traditional and genetically modified rodent models of human disease to support drug discovery and pre-clinical development programs.
Our main product lines are evaluation of test therapeutics and phenotypic characterization of genetically modified rodents. Offering both custom and standard pre-clinical services, our portfolio includes bioassays designed to support in vivo testing of potential therapeutics related to Immunology and Inflammation, Diabetes, Cardiovascular, Obesity, Neurodegenerative disorders, Cancer and other diseases. In vivo testing capabilities at Invivotek are supported by biochemical and molecular biology techniques, as well as functional assays using primary cell cultures established from various mouse tissues under disease model and normal conditions. These assays provide tools to study mechanism of action of various test therapeutics or potential target genes and to explore drug efficacy biomarkers.
Overview of Services